Healthcare Analytics is Fantastic

Healthcare Analytics is Fantastic

Healthcare analytics is fantastic, as the word is understood etymologically: “based on fantasy” [1]. Most of what is called “healthcare analytics” is in fact reporting, and what remains rarely meets the definition of analytics: “the method of logical analysis” [2]...

Tolkien and State Data

Tolkien and State Data

Like a modern-day Rip Van Winkle, I returned to the claims analytics industry in 2017 after a decade-long hiatus. Unlike Rip Van Winkle, I recently discovered that nothing has changed about the fascination that health system executives have with “state data”.

The 340B Program and the Road to Hell

The 340B Program and the Road to Hell

With the announcement by the Department of Health and Human Services (HHS) of the January 1, 2019 effective date of new, and lower, payments for drugs acquired under the 340B program, I was reminded of a post that my friend Wes Chapman published a little more than a..

Market Share: Three Common Fallacies

Market Share: Three Common Fallacies

Market share is “top of mind” for every savvy health system executive in America, even if definitions of market share are imprecise. Most often, health system executives think about market share in terms of the “PSA” and “SSA”, which is an elegant way of referring..

The Surprising Endurance of Status Quo in Healthcare Analytics

The Surprising Endurance of Status Quo in Healthcare Analytics

Status quo, as everyone knows, is Latin for the existing state of affairs, particularly in a political context. Ironically, the reliance on governmental and political organizations as the source of data analytics is the status quo for thousands of U.S. hospitals.

New Employer Strategy: Partner with Wal-Mart

New Employer Strategy: Partner with Wal-Mart

In 2007, I presented this paper to the Chief Strategy & Innovation Officer of the CDC and the EVP of Benefits of Wal-Mart proposing that they develop a Wal-Mart Provider Network and a Wal-Mart Health Plan with Humana. Wal-Mart estimated that the analysis would save..

Is Facebook Still a Viable Medium for Finding New Patients?

Is Facebook Still a Viable Medium for Finding New Patients?

It’s been a tumultuous year for Facebook. On top of the privacy scandal surrounding inappropriate data usage by Cambridge Analytica, they saw the worst single-day loss for any public company in history after an investor call on July 26. With questions around the..

8 Essential Questions to Ask Before Hiring an Analytics Partner

8 Essential Questions to Ask Before Hiring an Analytics Partner

In late June, Atul Gawande was named CEO of the headline-grabbing new healthcare venture from Amazon, JPMorgan and Berkshire Hathaway. Gawande, a surgeon, professor and writer, shot to fame after publishing a 2009 New Yorker article titled “The Cost Conundrum.”

HIMSS 2018 and EMR Atheism

HIMSS 2018 and EMR Atheism

Today is the first day of HIMSS 2018, a conference being held in Las Vegas in an exposition center in which the cheapest 10’ x 10’ booth costs $3,600 plus a $400 “booth listing fee” and attended by a number of people who speak frequently of the waste that is in..

Death, Taxes and Optum

Death, Taxes and Optum

The end of 2017 brings tidings of anything but great joy for health system executives. Consider what has happened in just the last 45 days: